Curiel DT - Search Results

1

Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein.

van Erp EA, Kaliberova LN, Kaliberov SA, Curiel DT. van Erp EA, et al. Among authors: curiel dt. Mol Ther Oncolytics. 2015 Feb 18;2:15001. doi: 10.1038/mto.2015.1. eCollection 2015. Mol Ther Oncolytics. 2015. PMID: 27119101 Free PMC article.

2

A novel system for mitigation of ectopic transgene expression induced by adenoviral vectors.

Reynolds PN, Holmes MD, Adachi Y, Kaliberova L, Curiel DT. Reynolds PN, et al. Among authors: curiel dt. Gene Ther. 2001 Aug;8(16):1271-5. doi: 10.1038/sj.gt.3301511. Gene Ther. 2001. PMID: 11509961

3

Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo.

Reynolds PN, Nicklin SA, Kaliberova L, Boatman BG, Grizzle WE, Balyasnikova IV, Baker AH, Danilov SM, Curiel DT. Reynolds PN, et al. Among authors: curiel dt. Nat Biotechnol. 2001 Sep;19(9):838-42. doi: 10.1038/nbt0901-838. Nat Biotechnol. 2001. PMID: 11533642

4

Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cells.

Kaliberov SA, Buchsbaum DJ, Gillespie GY, Curiel DT, Arafat WO, Carpenter M, Stackhouse MA. Kaliberov SA, et al. Among authors: curiel dt. Mol Ther. 2002 Aug;6(2):190-8. doi: 10.1006/mthe.2002.0648. Mol Ther. 2002. PMID: 12161185 Free article.

5

Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.

Zhu ZB, Makhija SK, Lu B, Wang M, Kaliberova L, Liu B, Rivera AA, Nettelbeck DM, Mahasreshti PJ, Leath CA 3rd, Yamamoto M, Alvarez RD, Curiel DT. Zhu ZB, et al. Among authors: curiel dt. Gene Ther. 2004 Apr;11(7):645-8. doi: 10.1038/sj.gt.3302089. Gene Ther. 2004. PMID: 15029227

6

Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application.

Takayama K, Reynolds PN, Adachi Y, Kaliberova L, Uchino J, Nakanishi Y, Curiel DT. Takayama K, et al. Among authors: curiel dt. Cancer Gene Ther. 2007 Jan;14(1):105-16. doi: 10.1038/sj.cgt.7700991. Epub 2006 Oct 6. Cancer Gene Ther. 2007. PMID: 17024232 Free PMC article.

7

Retargeting of gene expression using endothelium specific hexon modified adenoviral vector.

Kaliberov SA, Kaliberova LN, Hong Lu Z, Preuss MA, Barnes JA, Stockard CR, Grizzle WE, Arbeit JM, Curiel DT. Kaliberov SA, et al. Among authors: curiel dt. Virology. 2013 Dec;447(1-2):312-25. doi: 10.1016/j.virol.2013.09.020. Epub 2013 Oct 15. Virology. 2013. PMID: 24210128 Free PMC article.

8

Transcriptional targeting of primary and metastatic tumor neovasculature by an adenoviral type 5 roundabout4 vector in mice.

Lu ZH, Kaliberov S, Sohn RE, Kaliberova L, Curiel DT, Arbeit JM. Lu ZH, et al. Among authors: curiel dt. PLoS One. 2013 Dec 23;8(12):e83933. doi: 10.1371/journal.pone.0083933. eCollection 2013. PLoS One. 2013. PMID: 24376772 Free PMC article.

9

Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus.

Kaliberov SA, Kaliberova LN, Buchsbaum DJ, Curiel DT. Kaliberov SA, et al. Among authors: curiel dt. Cancer Gene Ther. 2014 Jul;21(7):264-74. doi: 10.1038/cgt.2014.26. Epub 2014 Jun 6. Cancer Gene Ther. 2014. PMID: 24903014 Free PMC article.

10

Adenoviral targeting using genetically incorporated camelid single variable domains.

Kaliberov SA, Kaliberova LN, Buggio M, Tremblay JM, Shoemaker CB, Curiel DT. Kaliberov SA, et al. Among authors: curiel dt. Lab Invest. 2014 Aug;94(8):893-905. doi: 10.1038/labinvest.2014.82. Epub 2014 Jun 16. Lab Invest. 2014. PMID: 24933423 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters